Access to Medicine – Patents versus Patients

the-bigger-picture · health-and-living · 7 Jan 2019 · 35 mins listen

Price gouging in the pharmaceutical industry has become a common feature of health news. Who can forget Martin Shkreli’s infamous price hike of the HIV drug Daraprim, which went from USD13.50 to $750 in the summer of 2015? Are international laws tough enough to ensure that the bottom line is the people and not profit?

Produced by:

Tina Carmillia

Presented by:

Meera Sivasothy

Categories:

Health Policy,Diseases and Conditions,Mental Health,Healthy Living,Fitness,Science,Medical Innovation and Technology

Tags:

international trade, intellectual property, access to medicine, patent, price control, compulsory license, cancer medicine, drug prices, sofosbuvir, health and living, the bigger picture

Related Content

Health & Living · 20 Nov 2024 · 36 mins

Finding Your Authentic Self

Paul Jambunathan, Consultant Clinical Psychologist

Health & Living · 19 Nov 2024 · 46 mins

Mind Matters: How Are Refugees in Malaysia Coping?

Sarah Ann Chou, Clinical Psychologist and Mental Health Activity Manager, Médecins Sans Frontières

Health & Living · 15 Nov 2024 · 39 mins

Helping Ovarian Cancer Patients Break Free!

Professor Dr Woo Yin Ling, Consultant Gynaecological OncologistImelda Yong, Programme Director & Co-founder, Breakfree MovementIren Lau, Group Lead, Ovarian Cancer Malaysia